Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFOXITIN vs CEFTAZIDIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFOXITIN vs CEFTAZIDIME: Safety Overview

Metric CEFOXITIN CEFTAZIDIME
Total FAERS Reports 750 3,158
Deaths Reported 48 696
Death Rate 6.4% 22.0%
Hospitalizations 252 1,503
Average Patient Age 50.8 yrs 52.0 yrs
% Female Patients 57.6% 43.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 28, 1989
Manufacturer B. Braun Medical Inc. Hospira, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Discontinued